HOLLIES MEDICAL CENTRE — All Prescriptions & Medications — Page 7
Practice Code: C88052 | SHEFFIELD, S11 9AL
Showing results 301-350 of 578
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Biphasic isophane insulin | 63 | 350 | £1.5K | -43.5% ▼ |
| Diclofenac sodium | 63 | 3,250 | £2.4K | +162.9% ▲ |
| Metoprolol tartrate | 62 | 2,541 | £1.9K | +22.2% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 62 | 361.1K | £7.2K | -11.4% ▼ |
| Pyridostigmine bromide | 60 | 12.0K | £947 | +250.5% ▲ |
| 60 | 145 | £743 | +266.1% ▲ | |
| Nitrazepam | 59 | 2,443 | £131 | +13.6% ▲ |
| Ondansetron hydrochloride | 59 | 2,337 | £766 | +21.6% ▲ |
| Insulin glargine | 59 | 250 | £2.3K | -79.2% ▼ |
| 59 | 59 | £139 | +82.1% ▲ | |
| Carvedilol | 58 | 2,822 | £104 | -48.9% ▼ |
| Alfuzosin hydrochloride | 58 | 2,682 | £618 | -18.9% ▼ |
| Terbinafine hydrochloride | 58 | 1,575 | £293 | +56.3% ▲ |
| 58 | 6,871 | £12.9K | +45.4% ▲ | |
| Glycerol | 57 | 1,030 | £161 | +62.5% ▲ |
| Valproic acid | 57 | 4,710 | £1.5K | -34.5% ▼ |
| Betamethasone sodium phosphate | 57 | 725 | £164 | +120.0% ▲ |
| Bempedoic acid/Ezetimibe | 56 | 1,820 | £3.4K | -8.3% ▼ |
| Orlistat | 56 | 4,984 | £1.2K | -32.1% ▼ |
| Primidone | 56 | 2,912 | £3.7K | +57.4% ▲ |
| Ursodeoxycholic acid | 54 | 6,288 | £1.4K | -18.4% ▼ |
| Degarelix | 54 | 54 | £6.3K | +211.1% ▲ |
| Other individually formulated bought in preparations | 54 | 1,501 | £306 | +65.3% ▲ |
| Trihexyphenidyl hydrochloride | 52 | 812 | £101 | +83.4% ▲ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 52 | 193.5K | £4.3K | +319.3% ▲ |
| Carmellose sodium | 52 | 5,010 | £762 | -19.8% ▼ |
| Acetylcysteine | 51 | 1,526 | £259 | -28.7% ▼ |
| Alfacalcidol | 51 | 2,610 | £420 | -58.8% ▼ |
| Permethrin | 51 | 2,580 | £663 | +35.4% ▲ |
| 51 | 648 | £1.4K | +16.0% ▲ | |
| Hyoscine hydrobromide | 50 | 1,980 | £317 | +46.4% ▲ |
| Pioglitazone hydrochloride | 50 | 2,100 | £183 | -43.5% ▼ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 50 | 245.9K | £4.6K | +31.0% ▲ |
| Meloxicam | 50 | 1,686 | £53 | -24.4% ▼ |
| Febuxostat | 50 | 2,716 | £213 | +33.9% ▲ |
| Betamethasone esters | 50 | 4,260 | £426 | -17.1% ▼ |
| Biphasic insulin lispro | 49 | 625 | £3.8K | +14.1% ▲ |
| Ivabradine | 48 | 3,374 | £1.1K | -49.5% ▼ |
| Anastrozole | 48 | 1,764 | £66 | -47.3% ▼ |
| 48 | 1,380 | £1.3K | +46.2% ▲ | |
| Hydroxyzine hydrochloride | 47 | 1,568 | £50 | -11.8% ▼ |
| Methylprednisolone acetate | 47 | 47 | £268 | -59.3% ▼ |
| Prednisolone acetate | 47 | 320 | £111 | +157.9% ▲ |
| Dalteparin sodium | 46 | 1,190 | £6.1K | +178.4% ▲ |
| Temazepam | 46 | 793 | £698 | -19.6% ▼ |
| 46 | 4,540 | £680 | +18.2% ▲ | |
| Umeclidinium bromide | 45 | 51 | £1.3K | -27.0% ▼ |
| Fosfomycin trometamol | 45 | 51 | £236 | +58.1% ▲ |
| Sitagliptin | 45 | 1,624 | £113 | -88.5% ▼ |
| Mometasone furoate/olopatadine hydrochloride | 45 | 48 | £608 | +314.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.